Infectious Disease Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064141
  • May 2021
  • Pharmaceuticals
  • 117 Pages
The global Infectious Disease Therapeutics market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Infectious Disease Therapeutics market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Infectious Disease Therapeutics market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Infectious Disease Therapeutics market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Merck and Co., Inc., Novartis AG, Pfizer, Inc., Boehringer Ingelheim GmbH, AbbVie, Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences, GlaxoSmithKline plc, AstraZeneca plc, Bayer AG
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Infectious Disease Therapeutics market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Infectious Disease Therapeutics market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Infectious Disease Therapeutics market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Infectious Disease Therapeutics market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Infectious Disease Therapeutics Market:
The Infectious Disease Therapeutics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Merck and Co., Inc., Novartis AG, Pfizer, Inc., Boehringer Ingelheim GmbH, AbbVie, Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences, GlaxoSmithKline plc, AstraZeneca plc, Bayer AG

Infectious Disease Therapeutics Market Segment Analysis:
By Drug Type
Anti-Bacterial
Anti-Viral
Anti-Parasite
Anti-Fungal
Disease Type
Bacterial
Viral
Fungal
Parasitic
Distribution Channel
Hospital and Retail Pharmacies
Independent Drug Stores
Online Pharmacies


Geographic Coverage for Infectious Disease Therapeutics Market:
The market research report on global Infectious Disease Therapeutics market offers complete analysis across various regions across the world. The Infectious Disease Therapeutics market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Infectious Disease Therapeutics market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Infectious Disease Therapeutics Market Value and Forecast
  • US
  • Canada
Europe Infectious Disease Therapeutics Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Infectious Disease Therapeutics Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Infectious Disease Therapeutics Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Infectious Disease Therapeutics Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Infectious Disease Therapeutics market report:
  • The report provides key trends of the global Infectious Disease Therapeutics market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Infectious Disease Therapeutics industry
  • The report covers all the recent developments of the Infectious Disease Therapeutics market and helps to provide current industry updates
  • The report covers a detailed look over the global Infectious Disease Therapeutics Industry and provides with significant actionable insights
  • The Infectious Disease Therapeutics market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Infectious Disease Therapeutics market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Infectious Disease Therapeutics market
  • Comprehensive analysis of the Infectious Disease Therapeutics market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Infectious Disease Therapeutics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Infectious Disease Therapeutics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Infectious Disease Therapeutics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Infectious Disease Therapeutics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Infectious Disease Therapeutics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Merck and Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH
  • AbbVie, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Bayer AG
  • Anti-Bacterial
  • Anti-Viral
  • Anti-Parasite
  • Anti-Fungal
  • Hospital and Retail Pharmacies
  • Independent Drug Stores
  • Online Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Infectious Disease Therapeutics Market Snapshot
          2.1.1. Global Infectious Disease Therapeutics Market By Drug Type,2019
               2.1.1.1.Anti-Bacterial
               2.1.1.2.Anti-Viral
               2.1.1.3.Anti-Parasite
               2.1.1.4.Anti-Fungal
          2.1.2. Global Infectious Disease Therapeutics Market By Distribution Channel,2019
               2.1.2.1.Hospital and Retail Pharmacies
               2.1.2.2.Independent Drug Stores
               2.1.2.3.Online Pharmacies
          2.1.3. Global Infectious Disease Therapeutics Market By End-use,2019
          2.1.4. Global Infectious Disease Therapeutics Market By Geography,2019

3. Global Infectious Disease Therapeutics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Infectious Disease Therapeutics Market Size (US$), By Drug Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Type, 2020
     4.2. Global Infectious Disease Therapeutics Market Size (US$), By Drug Type, 2018 – 2028

5. Global Infectious Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Infectious Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Infectious Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Infectious Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028

7. Global Infectious Disease Therapeutics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Infectious Disease Therapeutics Market Analysis, 2018 – 2028 
          7.2.1. North America Infectious Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Infectious Disease Therapeutics Market Size (US$), By Drug Type, 2018 – 2028
          7.2.3. North America Infectious Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Infectious Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Infectious Disease Therapeutics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Infectious Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Infectious Disease Therapeutics Market Size (US$), By Drug Type, 2018 – 2028
          7.3.3. Europe Infectious Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Infectious Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Infectious Disease Therapeutics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Infectious Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Infectious Disease Therapeutics Market Size (US$), By Drug Type, 2018 – 2028
          7.4.3. Asia Pacific Infectious Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Infectious Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Infectious Disease Therapeutics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Infectious Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Infectious Disease Therapeutics Market Size (US$), By Drug Type, 2018 – 2028
          7.5.3. Latin America Infectious Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Infectious Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Infectious Disease Therapeutics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Infectious Disease Therapeutics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Infectious Disease Therapeutics Market Size (US$), By Drug Type, 2018 – 2028
          7.6.3. MEA Infectious Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Infectious Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Infectious Disease Therapeutics Providers
        8.4.1 Merck and Co., Inc.
                8.4.1.1 Business Description
                8.4.1.2 Merck and Co., Inc. Geographic Operations
                8.4.1.3 Merck and Co., Inc. Financial Information
                8.4.1.4 Merck and Co., Inc. Product Positions/Portfolio
                8.4.1.5 Merck and Co., Inc. Key Developments
        8.4.2 Novartis AG
                8.4.2.1 Business Description
                8.4.2.2 Novartis AG Geographic Operations
                8.4.2.3 Novartis AG Financial Information
                8.4.2.4 Novartis AG Product Positions/Portfolio
                8.4.2.5 Novartis AG Key Developments
        8.4.3 Pfizer, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Pfizer, Inc. Geographic Operations
                8.4.3.3 Pfizer, Inc. Financial Information
                8.4.3.4 Pfizer, Inc. Product Positions/Portfolio
                8.4.3.5 Pfizer, Inc. Key Developments
        8.4.4 Boehringer Ingelheim GmbH
                8.4.4.1 Business Description
                8.4.4.2 Boehringer Ingelheim GmbH Geographic Operations
                8.4.4.3 Boehringer Ingelheim GmbH Financial Information
                8.4.4.4 Boehringer Ingelheim GmbH Product Positions/Portfolio
                8.4.4.5 Boehringer Ingelheim GmbH Key Developments
        8.4.5 AbbVie, Inc.
                8.4.5.1 Business Description
                8.4.5.2 AbbVie, Inc. Geographic Operations
                8.4.5.3 AbbVie, Inc. Financial Information
                8.4.5.4 AbbVie, Inc. Product Positions/Portfolio
                8.4.5.5 AbbVie, Inc. Key Developments
        8.4.6 F. Hoffmann-La Roche Ltd.
                8.4.6.1 Business Description
                8.4.6.2 F. Hoffmann-La Roche Ltd. Geographic Operations
                8.4.6.3 F. Hoffmann-La Roche Ltd. Financial Information
                8.4.6.4 F. Hoffmann-La Roche Ltd. Product Positions/Portfolio
                8.4.6.5 F. Hoffmann-La Roche Ltd. Key Developments
        8.4.7 Gilead Sciences
                8.4.7.1 Business Description
                8.4.7.2 Gilead Sciences Geographic Operations
                8.4.7.3 Gilead Sciences Financial Information
                8.4.7.4 Gilead Sciences Product Positions/Portfolio
                8.4.7.5 Gilead Sciences Key Developments
        8.4.8 GlaxoSmithKline plc
                8.4.8.1 Business Description
                8.4.8.2 GlaxoSmithKline plc Geographic Operations
                8.4.8.3 GlaxoSmithKline plc Financial Information
                8.4.8.4 GlaxoSmithKline plc Product Positions/Portfolio
                8.4.8.5 GlaxoSmithKline plc Key Developments
        8.4.9 AstraZeneca plc
                8.4.9.1 Business Description
                8.4.9.2 AstraZeneca plc Geographic Operations
                8.4.9.3 AstraZeneca plc Financial Information
                8.4.9.4 AstraZeneca plc Product Positions/Portfolio
                8.4.9.5 AstraZeneca plc Key Developments
        8.4.10 Bayer AG
                8.4.10.1 Business Description
                8.4.10.2 Bayer AG Geographic Operations
                8.4.10.3 Bayer AG Financial Information
                8.4.10.4 Bayer AG Product Positions/Portfolio
                8.4.10.5 Bayer AG Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Infectious Disease Therapeutics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Infectious Disease Therapeutics Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Infectious Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Infectious Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Infectious Disease Therapeutics Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Infectious Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Infectious Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Infectious Disease Therapeutics Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Infectious Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Infectious Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Infectious Disease Therapeutics Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Infectious Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Infectious Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Infectious Disease Therapeutics Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Infectious Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Infectious Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Infectious Disease Therapeutics: Market Segmentation 
FIG. 2 Global Infectious Disease Therapeutics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Infectious Disease Therapeutics Market, By Drug Type, 2019 (US$ Mn) 
FIG. 5 Global Infectious Disease Therapeutics Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Infectious Disease Therapeutics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Infectious Disease Therapeutics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Infectious Disease Therapeutics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Infectious Disease Therapeutics Providers, 2019
FIG. 11 Global Infectious Disease Therapeutics Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %) 
FIG. 12 Global Infectious Disease Therapeutics Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Infectious Disease Therapeutics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Infectious Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Infectious Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Infectious Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Infectious Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Infectious Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Infectious Disease Therapeutics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Infectious Disease Therapeutics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Infectious Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  North America Infectious Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  North America Infectious Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Europe Infectious Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Infectious Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Infectious Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Infectious Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Infectious Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Infectious Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Latin America Infectious Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Infectious Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Infectious Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  MEA Infectious Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Infectious Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Infectious Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Merck and Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AbbVie, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gilead Sciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Infectious Disease Therapeutics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Infectious Disease Therapeutics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Infectious Disease Therapeutics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Infectious Disease Therapeutics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Infectious Disease Therapeutics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Infectious Disease Therapeutics Providers, 2016
FIG.  Global Infectious Disease Therapeutics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Anti-Viral Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anti-Parasite Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anti-Fungal Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Infectious Disease Therapeutics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Independent Drug Stores Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Infectious Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)